Left Ventricular Assist Device and the Current State of the Art: HeartMate 3 at 5 Years

Omar Jawaid; Christopher Salerno; Ashwin Ravichandran

doi:10.1016/j.hfc.2023.05.005

Left Ventricular Assist Device and the Current State of the Art: HeartMate 3 at 5 Years

Heart Fail Clin. 2024 Jan;20(1):83-89. doi: 10.1016/j.hfc.2023.05.005. Epub 2023 Jul 11.

Authors

Omar Jawaid¹, Christopher Salerno², Ashwin Ravichandran³

Affiliations

¹ St. Vincents' Ascension, 8333 Naab Road, Indianapolis, IN 46260, USA.
² University of Chicago Medical Center, 5841 South Maryland Avenue, Chicago, IL 60637, USA.
³ St. Vincents' Ascension, 8333 Naab Road, Indianapolis, IN 46260, USA. Electronic address: ashwin.ravichandran@ascension.org.

PMID: 37953024
DOI: 10.1016/j.hfc.2023.05.005

Abstract

Left ventricular assist devices (LVADs) or cardiac transplantation are the two prevailing methods of treating patients with end-stage heart failure. The availability of donor hearts is insufficient to meet the needs of patients with advanced heart failure. LVADs offer a potential alternative to transplantation for those patients who cannot wait or are otherwise unsuited for cardiac transplantation. The field has made tremendous progress in the past 20 years. In this review, the current state of the art is summarized with respect to current generation LVADs.

Keywords: Durable mechanical support; End-stage cardiomyopathy; Heart failure; Outcomes.

Publication types

Review

MeSH terms

Heart Failure* / surgery
Heart Transplantation*
Heart-Assist Devices*
Humans
Tissue Donors